Literature DB >> 16123429

Noninvasive intraocular pressure measurements in mice by pneumotonometry.

Marcel Y Avila1, Alejandro Múnera, Arcadio Guzmán, Chi Wai Do, Zhao Wang, Richard A Stone, Mortimer M Civan.   

Abstract

PURPOSE: To develop a reliable, noninvasive, continuous, and easily implemented system for measuring intraocular pressure (IOP) in mice.
METHODS: Pneumotonometry was adapted for measurement of mouse IOP. Measurements were compared with those obtained with the servo-null micropipette system (SNMS) and with direct anterior chamber cannulation. Heart rate was monitored by the precordial pulse, EKG, or tail pulse in anesthetized mice. The characteristic ocular hypotensive response to mannitol was assessed as an additional validation of the
RESULTS: Measurements of IOP obtained using pneumotonometry agreed closely with values measured by SNMS or by direct cannulation. IOP oscillations were synchronous with the heart rate, with a coherence peak between them of approximately 2 Hz, equal to the pulse frequency. Hypertonic mannitol reduced IOP from 13.7 +/- 0.9 mm Hg by 7.7 +/- 0.7 mm Hg after 15 minutes.
CONCLUSIONS: Pneumotonometry is a reliable and noninvasive method for the measurement of IOP in mice and may permit comparisons of IOP to hemodynamic factors. This system is simpler and more adaptable for glaucoma research than previously reported methodologies for measuring IOP in mice.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16123429      PMCID: PMC1350969          DOI: 10.1167/iovs.04-1188

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  23 in total

1.  A(1)-, A(2A)- and A(3)-subtype adenosine receptors modulate intraocular pressure in the mouse.

Authors:  M Y Avila; R A Stone; M M Civan
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

2.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

3.  On the use of Tono-Pen XL for the measurement of intraocular pressure in mice.

Authors:  Claudia Dalke; Uwe Pleyer; Jochen Graw
Journal:  Exp Eye Res       Date:  2005-02       Impact factor: 3.467

4.  Reliable measurement of mouse intraocular pressure by a servo-null micropipette system.

Authors:  M Y Avila; D A Carré; R A Stone; M M Civan
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-07       Impact factor: 4.799

5.  Inhibitors of NHE-1 Na+/H+ exchange reduce mouse intraocular pressure.

Authors:  Marcel Y Avila; Randolph W Seidler; Richard A Stone; Mortimer M Civan
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-06       Impact factor: 4.799

6.  Measurement of intraocular pressure in awake mice.

Authors:  B E Cohan; D F Bohr
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-10       Impact factor: 4.799

7.  Reduction of intraocular pressure in mouse eyes treated with latanoprost.

Authors:  Makoto Aihara; James D Lindsey; Robert N Weinreb
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-01       Impact factor: 4.799

8.  Knockout of A3 adenosine receptors reduces mouse intraocular pressure.

Authors:  Marcel Y Avila; Richard A Stone; Mortimer M Civan
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-09       Impact factor: 4.799

9.  A system for monitoring heart pulse, respiration and posture in bed.

Authors:  Yasuaki Miyamoto; Yoshiharu Yonezawa; Hiromichi Maki; Hidekuni Ogawa; Allen W Hahn; W Morton Caldwell
Journal:  Biomed Sci Instrum       Date:  2002

10.  Intraocular pressure in genetically distinct mice: an update and strain survey.

Authors:  O V Savinova; F Sugiyama; J E Martin; S I Tomarev; B J Paigen; R S Smith; S W John
Journal:  BMC Genet       Date:  2001-08-09       Impact factor: 2.797

View more
  8 in total

1.  Calibration of the TonoLab tonometer in mice with spontaneous or experimental glaucoma.

Authors:  Mary E Pease; Frances E Cone; Scott Gelman; Janice L Son; Harry A Quigley
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-02-22       Impact factor: 4.799

2.  Nucleoside-derived antagonists to A3 adenosine receptors lower mouse intraocular pressure and act across species.

Authors:  Zhao Wang; Chi Wai Do; Marcel Y Avila; Kim Peterson-Yantorno; Richard A Stone; Zhan-Guo Gao; Bhalchandra Joshi; Pedro Besada; Lak Shin Jeong; Kenneth A Jacobson; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2009-10-28       Impact factor: 3.467

3.  Age differences in central and peripheral intraocular pressure using a rebound tonometer.

Authors:  J M González-Méijome; J Jorge; A Queirós; P Fernandes; R Montés-Micó; J B Almeida; M A Parafita
Journal:  Br J Ophthalmol       Date:  2006-08-02       Impact factor: 4.638

4.  Barrier qualities of the mouse eye to topically applied drugs.

Authors:  Zhao Wang; Chi Wai Do; Marcel Y Avila; Richard A Stone; Kenneth A Jacobson; Mortimer M Civan
Journal:  Exp Eye Res       Date:  2007-03-24       Impact factor: 3.467

Review 5.  Mouse models of retinal ganglion cell death and glaucoma.

Authors:  Stuart J McKinnon; Cassandra L Schlamp; Robert W Nickells
Journal:  Exp Eye Res       Date:  2008-12-07       Impact factor: 3.467

6.  The ocular pulse decreases aqueous humor outflow resistance by stimulating nitric oxide production.

Authors:  Michael Madekurozwa; W Daniel Stamer; Ester Reina-Torres; Joseph M Sherwood; Darryl R Overby
Journal:  Am J Physiol Cell Physiol       Date:  2021-01-13       Impact factor: 4.249

7.  The Magnitude of Hypotony and Time Course of Intraocular Pressure Recovery Following Anterior Chamber Cannulation in Nonhuman Primates.

Authors:  Jessica V Jasien; Carrie Huisingh; Christopher A Girkin; J Crawford Downs
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-06-01       Impact factor: 4.799

8.  Telemetric monitoring of 24 h intraocular pressure in conscious and freely moving C57BL/6J and CBA/CaJ mice.

Authors:  Ruixia Li; John H K Liu
Journal:  Mol Vis       Date:  2008-04-18       Impact factor: 2.367

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.